We are live on ! Find out more
TARA icon

Protara Therapeutics
TARA

33 hedge funds and large institutions have $118M invested in Protara Therapeutics in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 4

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

27% more capital invested

Capital invested by funds: $92.3M → $118M (+$25.2M)

18% more funds holding

Funds holding: 28 → 33 (+5)

0.1% more ownership

Funds ownership: 67.71% → 67.81% (+0.1%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
33
Holders Change
+5
Holders Change %
+17.86%
% of All Funds
0.68%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
13
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.84M
2
IC
Ikarian Capital
Texas
+$2.39M
3
State Street
State Street
Massachusetts
+$562K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$540K
5
Northern Trust
Northern Trust
Illinois
+$512K

Top Sellers

Rank Fund Capital Flow
1
DS
DRW Securities
Illinois
-$3.07M
2
A
Abingworth
United Kingdom
-$1.87M
3
Millennium Management
Millennium Management
New York
-$1.03M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$441K
5
Goldman Sachs
Goldman Sachs
New York
-$352K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$19K +$16.6K +537 +463%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$18K – – –
SO
28
STRS Ohio
Ohio
$14K +$15.5K +500 New
Legal & General Group
29
Legal & General Group
United Kingdom
$10K +$10.3K +332 New
Citigroup
30
Citigroup
New York
$8K -$48.1K -1,555 -86%
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
$5K +$5.26K +170 New
AIP
32
Ameritas Investment Partners
Nebraska
$5K +$5.51K +178 New
TRCT
33
Tower Research Capital (TRC)
New York
$3K +$1.64K +53 +136%
CIAS
34
CBIZ Investment Advisory Services
Ohio
$1K – – –
DS
35
DRW Securities
Illinois
– -$3.07M -133,543 Closed
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
– -$441K -18,674 Closed
Goldman Sachs
37
Goldman Sachs
New York
– -$352K -15,299 Closed
ECM
38
ExodusPoint Capital Management
New York
– -$216K -9,412 Closed
PA
39
Perceptive Advisors
New York
– -$184K -8,543 Closed
Victory Capital Management
40
Victory Capital Management
Texas
– -$42K -1,862 Closed
Macquarie Group
41
Macquarie Group
Australia
– -$8K -333 Closed
1
2

TARA Hedge Fund Activity: Q2 2020 in Review

33 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q2 2020, worth a combined $118M — up 27% from $92.3M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new TARA positions and 7 closed out — a net gain of 5 holders — while 13 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $2.84M. The largest seller was DRW Securities, exiting entirely with an estimated $3.07M sold.

  • 33 institutional investors held Protara Therapeutics (TARA) as of Q2 2020, up from 28 in Q1 2020.
  • Funds reported $118M of Protara Therapeutics stock for Q2 2020, up 27% quarter-over-quarter.
  • 12 funds opened new Protara Therapeutics positions in Q2 2020 and 7 closed out, a net change of +5 holders.
  • The largest Protara Therapeutics buyer in Q2 2020 was BlackRock, an estimated $2.84M added.
  • The largest Protara Therapeutics seller in Q2 2020 was DRW Securities, an estimated $3.07M sold.

Based on aggregated 13F filings for Q2 2020.